
ANSTO LifeSciences was inaugurated in 26 February 2010 to succeed and expand the activities of the former Radiopharmaceutical Research Institute (RRI).
As part of its inauguration, ANSTO LifeSciences has been formed with an organisational structure comprising five groups, with new infrastructure in place, including the 18 MeV dedicated research cyclotron at Camperdown, complemented by a shared ANSTO/BMRI/NIF pre-clinical imaging platform at the BMRI. In addition, a new Project Management Structure has been implemented.